Expression of cytokines in acute heart transplantation rejection

Abstract

The expression and changes of local cytokines network were detected in heart transplantation in rats, so as to determine the role of cytokines in the acute rejection of rats of heart transplantation. Allografts were divided into 4 groups (n=12 in each group): group A (control), group B (IL-2 monoclonal antibody-treated), group C (CsA-treated) and group D (IL-2 monoclonal antibody+CsA-treated). Hearts from DA rats were transplanted into a cervical location in Wistar recipients. The local expression of IL-1β, IL-2, CD25, IL-4, IL-5, IL-6, IL-10, TNFα and INFγ was detected at day 1, 3, 5, 7, 9, 11 and 14 by reverse transcription polymerase chain reaction. The results showed that the survival time of allografts was 8.3±1.7, 29.2±7.1 (P<0.05), 26.4±5.7 (P<0.05) and 55.0±10.6 (P<0.01) days respectively in groups A, B, C and D. The expression of IL-1β, IL-4, IL-10 and IFNγ was up-regulated, and that of IL-2, CD25, IL-5, IL-6 and TNFα was significantly inhibited in group A; The expression of IL-1β, IL-5, IL-6, IL-10 and IFNγ was up-regulated, and that of IL-2, IL-4 and TNFα was significantly down-regulated in group B; The expression of IL-1β, IL-2, CD25, IL-5, TNFα and IFNγ was up-regulated, and that of IL-4, IL-6 and IL-10 was significantly down-regulated in group C; The expression of IL-14, II-5, IL-6 and II-10 was up-regulated, and that of IL-1β, IL-2, CD25, TNFα and IFNγ was significantly down-regulated in group D. In conclusion, cytokines play an important role in the development of acute transplantation rejection. Different cytokines play different roles in different local environments.

Keywords

IL-2 monoclonal antibody / CsA / transplantation rejection / cytokine

References

[1] ChenShi.. Immunology of Transplantation, 1998, Wuhan, Huber Press of Science and Technology: 245-268

[2] XiaJ. H., YangC. Y.. The development and observation of auograft heart heteroptopic transplantation model in the neck in rats. Chin J of Experimental Surgery, 2000, 17: 565-567

[3] ExtonM. S., SchultM., DonathS., et al.. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am J Physiol, 1999, 276: 1710-1717

[4] PlainK. M., ChenJ., MertenS., et al.. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy. Transplantation, 1999, 67: 605-613

[5] ShirwanH., BarwariL., KhanN. S.. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokins in long-term allograft survival: induced by intrathymic immune modulation with donor class major histocompatibility complex peptides. Transplantation, 1998, 66: 1802-1809

[6] ZhaoX. M., YeohT. K., HiebertM., et al.. The expression of acidic fibroblast grouth factor (heparin-binding growth factor-1_ and cytolcine genes in human cardiac allografts and T cells. Transplantation, 1993, 56: 1177-1182

[7] FurukawaY., BeckerG., StinnJ. L., et al.. Interleukin-10 augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol, 1999, 155: 1929-1939

[8] HutchiusonI. V., PravicaV., PerreyC., et al.. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc, 1999, 31: 734-736

[9] GozzoJ., De FazioS.. Role of graft expression in the tolerogenicity of neonatal skin allografts. Transplant Proc, 1999, 31: 813

[10] LiW., FuF., LuL., et al.. Recipient pretreatment with mammalian IL10 prolongs mouse cardiac allografts survival by inhibition of antidonor T cell responses. Transplant Proc, 1999, 31: 115

[11] RowbottomA. W., LepperM. A., GarlandR. J., et al.. Interleukin-10-induced CD8 cell proliferation. Immunology, 1999, 98: 80-89

[12] BobH. S., RobertA. F., DawenB., et al.. Intragraft cytokine expression and tolerance induction in rat renal allografts. Transplantation, 1999, 67: 206-210

[13] GaoJ. X., MadrenasJ., ZengW., et al.. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T2 cell hyporesponesiveness in vitro and prevent acute allograft rejection. Immunology, 1999, 98: 159-170

[14] LiW., FuF., LuL., et al.. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation, 1998, 66: 1587-1596

[15] JiangH., YanyX. F., SorianoR., et al.. Inhibition of IL-10 by FK506 may be responsible for overcoming ongoing allograft rejection in the rat. Transplant Proc, 1999, 31: 1203-1205

[16] Mc Combe P A, Nickson I, Pender M P. Cytokine expression by inflammatory cells obtained from the spinal cords of Leuis rats with experimental basic protein and adjuvants.

[17] KoniecznyB. T., DaiZ., ElwoodE. T., et al.. IFN-gamma is critical for long term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol, 1998, 160: 2059-2064

[18] RaoA. S., StarzlT. E., DemetrisA. J., et al.. The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol, 1996, 80: S46-51

[19] KoS., NakanoH., DeiuickA., et al.. In vitro and in vivo effects of an anti-CD45 monoclonal antibody in the rat. Transplant Proc, 1993, 31: 1946-1947